Showing results (11-20 of 78) with videos related to

Sort By:
Pageof 8
Acta Oncologica (Stockholm, Sweden)|October 14, 2022
Immune checkpoint inhibitors in patients aged 80 or older with advanced non-small cell lung cancer or melanoma: a real-life multicentre studySoraya Benguerfi, Thierry Lesimple, Roch Houot, et al.
Melanoma Research|April 27, 2021
Prognostic impact of thyroid dysfunctions on progression-free survival in patients with metastatic melanoma treated with anti-PD-1 antibodiesAlexandra Frelau, Eva Jali, Boris Campillo-Gimenez, et al.
The British Journal of Dermatology|February 10, 2023
The concomitant use of proton pump inhibitors and BRAF/MEK inhibitors in metastatic melanomaFlorence Poizeau, Frédéric Balusson, Florian Lemaitre, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 1, 2005
Biodistribution of radiolabelled human dendritic cells injected by various routesVéronique Quillien, Annick Moisan, Andre Carsin, et al.
Breast Cancer Research and Treatment|June 26, 2013
A phase I dose escalation study to determine the optimal biological dose of irosustat, an oral steroid sulfatase inhibitor, in postmenopausal women with estrogen receptor-positive breast cancerR Charles Coombes, Fatima Cardoso, Nicolas Isambert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 14, 2022
Phase I Study of Androgen Deprivation Therapy in Combination with Anti-PD-1 in Melanoma Patients Pretreated with Anti-PD-1Caroline Robert, Céleste Lebbé, Thierry Lesimple, et al.
Breast Cancer Research : BCR|July 1, 2005
Dendritic cells are defective in breast cancer patients: a potential role for polyamine in this immunodeficiencyAlban Gervais, Jean Levêque, Françoise Bouet-Toussaint, et al.
Journal of Gynecology Obstetrics and Human Reproduction|February 16, 2021
Vulvar and vaginal melanomas: A retrospective study spanning 19 years from a tertiary centerMarine Joste, Ludivine Dion, Susie Brousse, et al.
Journal of Neuro-Oncology|December 23, 2003
Phase I study of topotecan in combination with concurrent radiotherapy in adults with glioblastomaThierry Lesimple, Mohammed B Hassel, Daniel Gédouin, et al.
Bulletin Du Cancer|January 20, 2012
[Retrospective analysis of 24 recurrent glioblastoma after chemoradiation and treated with nitrosoureas or irinotecan and bevacizumab]Elodie Vauleon, Habiba Mesbah, Daniel Gedouin, et al.
Pageof 8